Cargando…
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Chemotherapy is assuming an increasingly important role in the treatment of malignant gliomas, of which temozolomide (TMZ) is a key part. TMZ belongs to a class of second-generation imidazotetrazinone prodrugs that exhibit linear pharmacokinetics and do not require hepatic metabolism for activation...
Autores principales: | García, Margarita, Clopés, Ana, Bruna, Jordi, Martínez, María, Fort, Eduard, Gil, Miguel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004664/ https://www.ncbi.nlm.nih.gov/pubmed/21188132 |
Ejemplares similares
-
Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin
por: Salvo, Marissa C, et al.
Publicado: (2014) -
Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
por: Gould, Harry J, et al.
Publicado: (2015) -
Temozolomide as salvage treatment in primary brain lymphomas
por: Reni, M, et al.
Publicado: (2007) -
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Seewoodhary, Jason, et al.
Publicado: (2010) -
A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations
por: Weng, Judy, et al.
Publicado: (2023)